Kallelse till extra bolagsstämma den 26 feb
Mer information
Mentice presenterar Bokslutskommuniké Q4-2025 via livestream, 26 februari 2026, kl 10:00 CET
Registrera dig för livestream

Magnus Nilsson

Chairman of the Board
Chairman of the Remuneration Committee

Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Doctor of Medical Science from Uppsala University. Active as management consultant (non-listed companies). Other directorships in listed companies: board member of Cantargia AB and Corline AB. Former CEO of Xvivo Perfursion AB, CEO of Vitrolife AB and board member of the listed companies Immunicum AB and Dignitana AB.

Holdings

Aktier och optioner

Shareholding in Mentice: 26,000 shares

Independent

Oberoende

Independent in relation to the company, its management, and major shareholders.

Mentice to Present the Company's Year-End Q4 Report 2025 via Webcast, February 26, 2026, at 10:00 CET
Register now for webcast
Notice to attend the extraordinary shareholders’ meeting in Mentice AB - Feb 26
More information

Magnus Nilsson

Chairman of the Board
Chairman of the Remuneration Committee

Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Doctor of Medical Science from Uppsala University. Active as management consultant (non-listed companies). Other directorships in listed companies: board member of Cantargia AB and Corline AB. Former CEO of Xvivo Perfursion AB, CEO of Vitrolife AB and board member of the listed companies Immunicum AB and Dignitana AB.

Holdings

Aktier och optioner

Shareholding in Mentice: 26,000 shares

Independent

Oberoende

Independent in relation to the company, its management, and major shareholders.